Trends in left ventricular assist device use and outcomes among Medicare beneficiaries, 2004-2011
- PMID: 25332817
- PMCID: PMC4189322
- DOI: 10.1136/openhrt-2014-000109
Trends in left ventricular assist device use and outcomes among Medicare beneficiaries, 2004-2011
Abstract
Objective: To characterise the trends in the left ventricular assist device (LVAD) implantation rates and outcomes between 2004 and 2011 in the Medicare population. Since the approval of the HeartMate II in 2008, the use of LVADs has steadily climbed. Given the increase in LVAD use, issues around discharge disposition, post-implant hospitalisations and costs require further understanding.
Methods: We examined LVAD implantation rates and short-term and long-term outcomes among Medicare fee-for-service beneficiaries hospitalised for LVAD implantation. We also conducted analyses among survivors 1-year post-discharge to examine rehospitalisation rates. Lastly, we reported Centers for Medicare & Medicaid Services (CMS) payments for both index hospitalisation and rehospitalisations 1 year post-discharge.
Results: A total of 2152 LVAD implantations were performed with numbers increasing from 107 in 2004 to 612 in 2011. The 30-day mortality rate decreased from 52% to 9%, and 1-year mortality rate decreased from 69% to 31%. We observed no change in overall length of stay, but post-procedure length of stay increased. We also found an increase in home discharge dispositions from 26% to 53%. Between 2004 and 2010, the rehospitalisation rate increased and the number of hospital days decreased. The adjusted CMS payment for the index hospitalisation increased from $188 789 to $225 697 over time but decreased for rehospitalisation from $60 647 to $53 630.
Conclusions: LVAD implantations increased over time. We found decreasing 30-day and 1-year mortality rates and increasing home discharge disposition. The proportion of patients rehospitalised among 1-year survivors remained high with increasing index hospitalisation cost, but decreasing post-implantation costs over time.
Keywords: HEART FAILURE.
Figures
References
-
- Rose EA, Gelijns AC, Moskowitz AJ, et al. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med 2001;345:1435–43 - PubMed
-
- US Food and Drug Administration . Department of Health and Human Services. Device Approvals and Clearances. http://www.accessdata.fda.gov/cdrh_docs/pdf6/p060040a.pdf (accessed 1 Oct 2013).
-
- Centers for Medicare & Medicaid Services. Decision memo for ventricular assist devices as destination therapy (CAG-00119N). http://www.cms.hhs.gov/mcd/viewdecisionmemo.asp?id=79. (accessed 12 Jul 2013)
-
- Hunt SA, Abraham WT, Chin MH, et al. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol 2005;46:e1–82 - PubMed
-
- National Heart, Lung and Blood Institute. Workshop, Meeting Summaries, Scientific Reports. http://www.nhlbi.nih.gov/meetings/workshops/nextgen-vads.htm. (accessed 12 Jul 2012).
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources